During the past decade, GCS des hôpitaux pédiatriques conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "GCS des hôpitaux pédiatriques" are "Peanut Allergy" (2 trials). Many other conditions were trialed in "GCS des hôpitaux pédiatriques" in a lesser frequency.

Most popular intervention types in "GCS des hôpitaux pédiatriques" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Viaskin Peanut 250 mcg" (2 trials), "Viaskin Peanut 100 mcg" (1 trials), "Viaskin Peanut 50 mcg" (1 trials) and "Viaskin Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "GCS des hôpitaux pédiatriques" are 2 trials for "All" genders.

Currently, there are NaN active trials in "GCS des hôpitaux pédiatriques". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in GCS des hôpitaux pédiatriques, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GCS des hôpitaux pédiatriques, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".